However, as this study is based on in silico approaches, future work should include in vitro and in vivo validation—such as evaluating the effects of these compounds on cancer cell proliferation and HSP90 activity—along with bioavailability optimization and structural refinement to enhance selectivity. Here, HSP90AA1 is linked to cancer.